​Independence Blue Cross and Independence Administrators updated several policies last month. Effective December 19, 2022, published policies include:

• Commercial: #08.01.11h: Ado-Trastuzumab Emtansine (Kadcyla^®)
• Commercial: #07.02.21j: Ambulatory Electrocardiography (AECG) Monitoring and Mobile Cardiac Outpatient Telemetry (MCOT) Monitoring
  

To view the latest medical and claim payment policy bulletins, visit the Medical and Claim Payment Policy Portal.

For important policy information related to COVID-19, visit the Commercial and Medicare Advantage News & Announcements sections of the portal.